We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Rehabilitation for chronic neurological disorders including acquired brain injury Draft guidance consultation NICE guideline 20 May 2025 Pneumonia: diagnosis and management (update) Draft guidance ...

For further information on our processes and methods, please see our quality standards process guide.

Hormone receptor (HR)-positive HER2-negative advanced breast cancer is incurable and the aim of treatment is to delay it getting worse and extend how long people live. If the cancer has alterations in ...

Erdafitinib, also known as Balversa and made by Johnson & Johnson, is recommended in final draft guidance for adults with metastatic or unresectable FGFR-altered urothelial cancer who have previously ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

All NICE products on vulnerable groups. Includes any guidance and quality standards.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

When people with care and support needs transfer into and out of hospital, good communication and integrated services are essential. Without this, people can experience: unmet care and support needs ...

The recommendations in this section are displayed alphabetically by symptom then in order of urgency of the action needed, to make sure that the most urgent actions are not missed. Where there are ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.